2023
Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination
Fitzpatrick M, Moghadas S, Vilches T, Shah A, Pandey A, Galvani A. Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination. JAMA Network Open 2023, 6: e2313586. PMID: 37204795, PMCID: PMC10199352, DOI: 10.1001/jamanetworkopen.2023.13586.Peer-Reviewed Original ResearchConceptsBooster campaignBooster vaccinationInfluenza vaccinationPediatric populationDecision analytical modelSchool absenteeismIntensive carePediatric hospitalizationsEligible individualsMAIN OUTCOMEAge groupsIntensive care unit admissionCare unit admissionSeasonal influenza vaccinationCOVID-19 illnessCOVID-19 prevention strategiesEligible age groupDecreased hospitalizationsUnit admissionCOVID-19 transmissionSymptomatic infectionAdverse outcomesIsolation daysHospitalizationGeneral population
2022
Return on Investment of the COVID-19 Vaccination Campaign in New York City
Sah P, Vilches T, Moghadas S, Pandey A, Gondi S, Schneider E, Singer J, Chokshi D, Galvani A. Return on Investment of the COVID-19 Vaccination Campaign in New York City. JAMA Network Open 2022, 5: e2243127. PMID: 36409495, PMCID: PMC9679875, DOI: 10.1001/jamanetworkopen.2022.43127.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccination campaignVaccination campaignIntensive care unit admissionCare unit admissionEmergency department visitsIndirect costsDecision analytical modelEmergency medical servicesCOVID-19 deathsHealth care expendituresUnit admissionDepartment visitsFuture COVID-19 outbreaksNew York CityOutpatient visitsVaccine uptakeSevere outcomesVaccination programPotential yearsMAIN OUTCOMEVaccinationHealth outcomesProbable casesSocietal perspectiveCare expendituresUniversal healthcare as pandemic preparedness: The lives and costs that could have been saved during the COVID-19 pandemic
Galvani AP, Parpia AS, Pandey A, Sah P, Colón K, Friedman G, Campbell T, Kahn JG, Singer BH, Fitzpatrick MC. Universal healthcare as pandemic preparedness: The lives and costs that could have been saved during the COVID-19 pandemic. Proceedings Of The National Academy Of Sciences Of The United States Of America 2022, 119: e2200536119. PMID: 35696578, PMCID: PMC9231482, DOI: 10.1073/pnas.2200536119.Peer-Reviewed Original ResearchModeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India
Du Z, Wang L, Pandey A, Lim WW, Chinazzi M, Piontti APY, Lau EHY, Wu P, Malani A, Cobey S, Cowling BJ. Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India. Nature Medicine 2022, 28: 934-938. PMID: 35210596, PMCID: PMC9117137, DOI: 10.1038/s41591-022-01736-z.Peer-Reviewed Original ResearchConceptsLarge-scale survey dataEconomic benefitsFull dose vaccinationSurvey dataHospital admission costsDose-sparing strategiesCost of hospitalizationCOVID-19 deathsPopulation-level transmissionVaccine dosesVaccination strategiesAdmission costsEconomic burdenVaccine shortageFractional dosesVaccinationDose fractionationHigh transmissibilityVaccine distributionCostPublic healthVaccineWillingnessDosesIndia
2021
Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout
Pandey A, Sah P, Moghadas SM, Mandal S, Banerjee S, Hotez PJ, Galvani AP. Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout. Journal Of Global Health 2021, 11: 03083. PMID: 34221355, PMCID: PMC8243816, DOI: 10.7189/jogh.11.03083.Peer-Reviewed Original ResearchRole of the G20 in safe reopening of international travel
Pandey A, Galvani AP. Role of the G20 in safe reopening of international travel. The Lancet Infectious Diseases 2021, 21: 919. PMID: 34174233, DOI: 10.1016/s1473-3099(21)00341-8.Peer-Reviewed Original ResearchComparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study
Du Z, Pandey A, Bai Y, Fitzpatrick MC, Chinazzi M, Pastore Y Piontti A, Lachmann M, Vespignani A, Cowling BJ, Galvani AP, Meyers LA. Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study. The Lancet Public Health 2021, 6: e184-e191. PMID: 33549196, PMCID: PMC7862022, DOI: 10.1016/s2468-2667(21)00002-5.Peer-Reviewed Original ResearchConceptsLow transmission scenarioSARS-CoV-2 testing programSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2SARS-CoV-2 transmissionSymptom-based testingSyndrome coronavirus 2Viral load dynamicsYLL avertedSARS-CoV-2 testing strategyTesting strategiesPositive test resultsCOVID-19 pandemicYears of lifeIsolation periodCoronavirus 2US National InstitutesViral testingPhysical distancing measuresEfficacious vaccineUS CentersAntiviral drugsIsolation durationEffective reproduction numberOptimal COVID-19 quarantine and testing strategies
Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer B, McDonald RH, Fitzpatrick MC, Galvani AP. Optimal COVID-19 quarantine and testing strategies. Nature Communications 2021, 12: 356. PMID: 33414470, PMCID: PMC7788536, DOI: 10.1038/s41467-020-20742-8.Peer-Reviewed Original Research
2020
The implications of silent transmission for the control of COVID-19 outbreaks
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP. The implications of silent transmission for the control of COVID-19 outbreaks. Proceedings Of The National Academy Of Sciences Of The United States Of America 2020, 117: 17513-17515. PMID: 32632012, PMCID: PMC7395516, DOI: 10.1073/pnas.2008373117.Peer-Reviewed Original ResearchConceptsSilent infectionSymptomatic casesAsymptomatic transmissionSilent transmissionPopulation-wide restrictionsRisk of resurgenceRapid contact tracingRecent individual-level dataCoronavirus disease 2019Symptom onsetAsymptomatic proportionAsymptomatic infectionDisease 2019Majority of incidencesPresymptomatic stagePresymptomatic casesInfected individualsContact tracingInfectionFuture outbreaksCOVID-19 outbreakSocial distancing measuresOne-thirdMovement restrictionsDistancing measuresImpact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak
Wells CR, Sah P, Moghadas SM, Pandey A, Shoukat A, Wang Y, Wang Z, Meyers LA, Singer BH, Galvani AP. Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak. Proceedings Of The National Academy Of Sciences Of The United States Of America 2020, 117: 7504-7509. PMID: 32170017, PMCID: PMC7132249, DOI: 10.1073/pnas.2002616117.Peer-Reviewed Original ResearchConceptsAppropriate public health responseSARS-CoV-2 casesSevere acute respiratory syndrome casesCOVID-19 outbreakImportation of casesPublic health responseInternational travelControl measuresSyndrome casesCoronavirus outbreakHealth responseGlobal spreadTravel restrictionsNovel coronavirus outbreakBorder control measuresDaily riskHalf weeksOutbreakEarly stagesCasesMainland China